Generate hcc case with one slide for case one slide for mdt questions (medical oncologist- intervenal radiologist and hepatic surgeon) then answer with supported evidence, taking in consideration it is roch sponosred meeting to navigate critical cases favours atezo beva as ttt option
Generate hcc case with one slide for case one slide for mdt questions (medical oncologist- intervenal radiologist and hepatic surgeon) then answer with supported evidence, taking in consideration it is roch sponosred meeting to navigate critical cases favours atezo beva as ttt option
Created using ChatSlide
This case study focuses on a critical decision point in hepatocellular carcinoma (HCC) management, detailing patient profiles, imaging assessments, and multidisciplinary team (MDT) resolutions. It explores three specialist perspectives—oncologist, radiologist, and surgeon—on treatment options like atezolizumab-bevacizumab, locoregional therapy, and surgical feasibility. The final section emphasizes an evidence-based action plan, applying IMbrave150 findings while considering risks and...